Isolation and characterization of DNA from the plasma of cancer patients
Abstract
Unlabelled Ten out of 37 patients with advanced malignant diseases were found to have extractable amounts of DNA in their plasma whereas no DNA could be detected in 50 normal controls. After its purification from the original nucleoprotein complex, DNA plasma levels ranging from 0.15 to 12 micrograms/ml were measured, the lowest concentration detectable with our method being 0.1 microgram/ml. Knowing from recovery experiments performed with 32P-DNA that the loss of DNA during the extraction procedure is about 65%, the real concentration of DNA in the plasma corresponds to about 3 times the given figures. The purified DNA was shown to be double-stranded and composed of fractions ranging from 21 kb to less than 0.5 kb, as determined by agarose gel electrophoresis. All these fractions hybridized with a 32P-labelled human DNA probe indicating the human origin of the bulk of the circulating DNA.In conclusion the finding of extractable amounts of DNA in the plasma of 27% of the investigated cancer patients, and its absence from the controls, suggests some correlation with malignancy.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The discovery of cell free DNA (cfDNA) in blood plasma has provided a simple source of genetic material for pre-natal and tumour diagnosis.
“The discovery of cell free DNA (cfDNA) in blood plasma has provided a simple source of genetic material for pre-natal and tumour diagnosis (13–18) that could potentially enable routine minimally invasive sampling for subsequent CNV analysis.”
From Comparison of microfluidic digital PCR and conventional quantitative PCR for measuring copy number variation (2012) · cites this paper as [14]
Cites
Rigby, P. W. J., Dieckmann, M., Rhodes, C., & Berg, P. R. (1977) · Journal of Molecular Biology · doi:10.1016/0022-2836(77)90052-3 · Cited by 11,400 · see citing works
(1977) · PubMed · Cited by 1,801 · see citing works
Shapiro, B., Chakrabarty, M., Cohn, E. M., & Leon, S. A. (1983) · Cancer · doi:10.1002/1097-0142(19830601)51:11 · Cited by 398 · see citing works
Spontaneous release of DNA by human blood lymphocytes as shown in an in vitro system.
Anker, P., Stroun, M., & Maurice, P. A. (1975) · PubMed · Cited by 234 · see citing works
Self-citationExcretion of Deoxyribonucleic Acid by Lymphocytes Stimulated with Phytohemagglutinin or Antigen
ROGERS, J. C., Boldt, D. H., Kornfeld, S. A., Skinner, S. A. M., & VALERI, C. R. (1972) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.69.7.1685 · Cited by 158 · see citing works
Circulating Nucleic Acids in Higher Organisms
Stroun, M., Anker, P., Maurice, P. A., & Gahan, P. B. (1977) · International review of cytology · doi:10.1016/s0074-7696(08)60225-9 · Cited by 106 · see citing works
Self-citationCirculating DNA in systemic lupus erythematosus. Isolation and characterization.
Steinman, C. R. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111278 · Cited by 99 · see citing works
Wieczorek, A. J., Rhyner, C., & Block, L. H. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.10.3455 · Cited by 97 · see citing works
Circulating DNA in systemic lupus erythematosus
Steinman, C. R. (1979) · The American Journal of Medicine · doi:10.1016/0002-9343(79)90789-7 · Cited by 95 · see citing works
Aggarwal, S. K., Wagner, R. W., McAllister, P. K., & Rosenberg, B. H. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.3.928 · Cited by 79 · see citing works
Nucleic acids spontaneously released by living frog auricles
Stroun, M., & Anker, P. (1972) · Biochemical Journal · doi:10.1042/bj1280100pb · Cited by 69 · see citing works
Self-citationJuckett, D. A., & Rosenberg, B. (1982) · PubMed · Cited by 38 · see citing works
The DNA extruded by rat spleen cells in culture
Adams, D., & Gahan, P. B. (1983) · International Journal of Biochemistry · doi:10.1016/0020-711x(83)90129-5 · Cited by 22 · see citing works
Leukemia in AKR mice: A defined suppressor cell population expressing membrane-associated DNA
Russell, J. L., & Golub, E. S. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.12.6211 · Cited by 21 · see citing works
Purification of DNA by affinity chromatography: Removal of polysaccharide contaminants
Edelman, M. (1975) · Analytical Biochemistry · doi:10.1016/0003-2697(75)90512-6 · Cited by 15 · see citing works
Spontaneous release of newly synthesized DNA from frog auricles
Stroun, M., Anker, P., & Gahan, P. (1977) · E-Periodica · doi:10.5169/seals-739823 · Cited by 13 · see citing works
Self-citationNEURATH, A. R., Strick, N., Miller, K., & Waldman, A. A. (1984) · Journal of Virological Methods · doi:10.1016/0166-0934(84)90042-9 · Cited by 9 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
A view on drug resistance in cancer
Vasan, N., Baselga, J., & Hyman, D. M. (2019) · Nature · doi:10.1038/s41586-019-1730-1 · Cited by 2,770 · see citing works
Direct detection of early-stage cancers using circulating tumor DNA
Phallen, J. A., Sausen, M., Adleff, V., Leal, A., Hruban, C., White, J. R., Anagnostou, V., Fiksel, J., Cristiano, S., Papp, E., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aan2415 · Cited by 1,129 · see citing works
Origins, structures, and functions of circulating DNA in oncology
Thierry, A. R., El Messaoudi, S., Gahan, P. B., Anker, P., & Stroun, M. (2016) · Cancer and Metastasis Reviews · doi:10.1007/s10555-016-9629-x · Cited by 818 · see citing works
Self-citationHigh-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants
Razavi, P., Li, B. T., Brown, D. N., Jung, B., Hubbell, E. A., Shen, R., Abida, W. M., Juluru, K., de Bruijn, I., Hou, C., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0652-7 · Cited by 795 · see citing works
Advances in bladder cancer biology and therapy
Tran, L. L., Xiao, J.-F., Agarwal, N., Duex, J. E., & Theodorescu, D. (2020) · Nature reviews. Cancer · doi:10.1038/s41568-020-00313-1 · Cited by 742 · see citing works
Lanman, R. B., Mortimer, S. A., Zill, O. A., Sebisanovic, D., Lopez, R., Blau, S., Collisson, E. A., Divers, S. G., Hoon, D. S. B., Kopetz, E. S., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140712 · Cited by 695 · see citing works
Blood-Based Analyses of Cancer: Circulating Tumor Cells and Circulating Tumor DNA
Haber, D. A., & Velculescu, V. E. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-1014 · Cited by 697 · see citing works
Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA
Thierry, A. R., Mouliere, F. C., Messaoudi, S. E., Mollévi, C., Lopez‐Crapez, E., Rolet, F., Gillet, B., Gongora, C., Dechelotte, P., Robert, B., et al. (2014) · Nature Medicine · doi:10.1038/nm.3511 · Cited by 681 · see citing works
Microsatellite alterations in serum DNA of head and neck cancer patients
Nawroz, H., Koch, W. M., Anker, P., Stroun, M., & Sidransky, D. (1996) · Nature Medicine · doi:10.1038/nm0996-1035 · Cited by 656 · see citing works
Self-citationCirculating cell free DNA: Preanalytical considerations
Messaoudi, S. E., Rolet, F., Mouliere, F. C., & Thierry, A. R. (2013) · Clinica Chimica Acta · doi:10.1016/j.cca.2013.05.022 · Cited by 560 · see citing works
Enhancing the accuracy of next-generation sequencing for detecting rare and subclonal mutations
Salk, J. J., Schmitt, M. W., & Loeb, L. A. (2018) · Nature Reviews Genetics · doi:10.1038/nrg.2017.117 · Cited by 536 · see citing works
Detection and Clinical Importance of Micrometastatic Disease
Pantel, K., Côté, R. J., & Fodstad, Ø. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.13.1113 · Cited by 493 · see citing works
Whale, A. S., Huggett, J. F., Cowen, S., Speirs, V., Shaw, J., Ellison, S., Foy, C. A., & Scott, D. J. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks203 · Cited by 453 · see citing works
Detection of Circulating Tumour DNA in the Blood (Plasma/Serum) of Cancer Patients
Anker, P., Mulcahy, H. E., Chen, X. Q., & Stroun, M. (1999) · Cancer and Metastasis Reviews · doi:10.1023/a:1006260319913 · Cited by 451 · see citing works
Self-citationGormally, E., Caboux, É., Vineis, P., & Hainaut, P. L. (2007) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2006.11.002 · Cited by 444 · see citing works
Vasioukhin, V. I., Anker, P., Maurice, P. A., Lyautey, J., Lederrey, C., & Stroun, M. (1994) · British Journal of Haematology · doi:10.1111/j.1365-2141.1994.tb04828.x · Cited by 413 · see citing works
Self-citationRosas, S. L. B., Koch, W. M., Carvalho, M. D. G., Wu, L., Califano, J. A., Westra, W. H., Jen, J., & Sidransky, D. (2001) · PubMed · Cited by 409 · see citing works
Nucleic Acid-Based Methods for the Detection of Cancer
Sidransky, D. (1997) · Science · doi:10.1126/science.278.5340.1054 · Cited by 405 · see citing works
The Origin and Mechanism of Circulating DNA
Stroun, M., Maurice, P. A., Vasioukhin, V. I., Lyautey, J., Lederrey, C., Lefort, F., ROSSIER, A., Chen, X. Q., & Anker, P. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06608.x · Cited by 395 · see citing works
Self-citationCell-free DNA in the blood as a solid tumor biomarker–a critical appraisal of the literature
Jung, K., Fleischhacker, M., & Rabien, A. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.07.032 · Cited by 337 · see citing works
Aucamp, J., Bronkhorst, A. J., Badenhorst, C. P. S., & Pretorius, P. J. (2018) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.12413 · Cited by 325 · see citing works
Circulating nucleic acids (CNAs) and cancer—A survey
Fleischhacker, M., & Schmidt, B. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.10.001 · Cited by 851 · see citing works
The Long and Short of Circulating Cell-Free DNA and the Ins and Outs of Molecular Diagnostics
Jiang, P., & Lo, Y. M. D. (2016) · Trends in Genetics · doi:10.1016/j.tig.2016.03.009 · Cited by 309 · see citing works
Lee, T., Montalvo, L., Chrebtow, V., & Busch, M. P. (2001) · Transfusion · doi:10.1046/j.1537-2995.2001.41020276.x · Cited by 311 · see citing works
Pan-cancer circulating tumor DNA detection in over 10,000 Chinese patients
Zhang, Y., Yao, Y., Xu, Y., Li, L., Gong, Y., Zhang, K., Zhang, M., Guan, Y., Chang, L., Xia, X., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-20162-8 · Cited by 306 · see citing works
Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts
Thierry, A. R., Mouliere, F. C., Gongora, C., Ollier, J., Robert, B., Ychou, M., Rio, M. D., & Molina, F. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq421 · Cited by 299 · see citing works
Devonshire, A. S., Whale, A. S., Gutteridge, A., Jones, G. M., Cowen, S., Foy, C. A., & Huggett, J. F. (2014) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-014-7835-3 · Cited by 299 · see citing works
Evaluating the analytical validity of circulating tumor DNA sequencing assays for precision oncology
Deveson, I. W., Gong, B., Lai, K., LoCoco, J. S., Richmond, T., Schageman, J. J., Zhang, Z., Novoradovskaya, N., Willey, J. C., Jones, W. D., et al. (2021) · Nature Biotechnology · doi:10.1038/s41587-021-00857-z · Cited by 280 · see citing works
An electrochemical clamp assay for direct, rapid analysis of circulating nucleic acids in serum
Das, J., Ivanov, I., Montermini, L., Rak, J. W., Sargent, E. H., & Kelley, S. O. (2015) · Nature Chemistry · doi:10.1038/nchem.2270 · Cited by 274 · see citing works
Guidelines for the Preanalytical Conditions for Analyzing Circulating Cell-Free DNA
Meddeb, R., Pisareva, E., & Thierry, A. R. (2019) · Clinical Chemistry · doi:10.1373/clinchem.2018.298323 · Cited by 263 · see citing works
Postel, M., Roosen, A., Laurent‐Puig, P., Taly, V., & Renault, S. (2017) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2018.1400384 · Cited by 255 · see citing works
Genomic Medicine–Progress, Pitfalls, and Promise
Shendure, J., Findlay, G. M., & Snyder, M. W. (2019) · Cell · doi:10.1016/j.cell.2019.02.003 · Cited by 253 · see citing works
Sanmamed, M. F., Landazuri, S. F., Rodríguez, C., Zárate, R., Lozano, M. D., Zubiri, L., Perez‐Gracia, J. L., Martín‐Algarra, S., & González, Á. (2014) · Clinical Chemistry · doi:10.1373/clinchem.2014.230235 · Cited by 245 · see citing works
Quantifying circulating cell-free DNA in humans
Meddeb, R., Dache, Z. A. A., Thézenas, S., Otandault, A., Tanos, R., Pastor, B., Sánchez, C., Azzi, J., Tousch, G., Azan, S., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-41593-4 · Cited by 242 · see citing works
Su, Y., Wang, M., Brenner, D. E., Ng, A. K. L., Melkonyan, H. S., Umansky, S. R., Syngal, S., & Block, T. M. (2004) · Journal of Molecular Diagnostics · doi:10.1016/s1525-1578(10)60497-7 · Cited by 240 · see citing works
Mouliere, F. C., Messaoudi, S. E., Pang, D., Dritschilo, A., & Thierry, A. R. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.02.005 · Cited by 228 · see citing works
Cell-free DNA: measurement in various carcinomas and establishment of normal reference range
Wu, T., Zhang, D., Chia, J., Tsao, K., Sun, C., & Wu, J. T. (2002) · Clinica Chimica Acta · doi:10.1016/s0009-8981(02)00091-8 · Cited by 231 · see citing works
Circulating DNA: a new diagnostic gold mine?
Ziegler, A., Zangemeister‐Wittke, U., & Stahel, R. A. (2002) · Cancer Treatment Reviews · doi:10.1016/s0305-7372(02)00077-4 · Cited by 229 · see citing works
Grabuschnig, S., Bronkhorst, A. J., Holdenrieder, S., Rodriguez, I. R., Schliep, K. P., Schwendenwein, D., Ungerer, V., & Sensen, C. W. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218062 · Cited by 223 · see citing works
Extracellular DNA and histones: double‐edged swords in immunothrombosis
Gould, T. J., Lysov, Z., & Liaw, P. C. (2015) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12977 · Cited by 218 · see citing works
Breitbach, S. A., Tug, S., & Simon, P. D. (2012) · Sports Medicine · doi:10.2165/11631380-000000000-00000 · Cited by 209 · see citing works
A prospective study of K-ras mutations in the plasma of pancreatic cancer patients.
Mulcahy, H. E., Lyautey, J., Lederrey, C., Chen, X. Q., Anker, P., Alstead, E. M., Ballinger, A., Farthing, M. J. G., & Stroun, M. (1998) · PubMed · Cited by 205 · see citing works
Self-citationClinical use of circulating nucleosomes
Holdenrieder, S., & Stieber, P. (2009) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360802485875 · Cited by 200 · see citing works
Choi, J., Reich, C. F., & Pisetsky, D. S. (2005) · Immunology · doi:10.1111/j.1365-2567.2005.02130.x · Cited by 199 · see citing works
Detecting tumor-related alterations in plasma or serum DNA of patients diagnosed with breast cancer.
Chen, X., Bonnefoi, H. R., Diebold‐Berger, S., Lyautey, J., Lederrey, C., Faltin-Traub, E. F., Stroun, M., & Anker, P. (1999) · PubMed · Cited by 193 · see citing works
Self-citationvan der Vaart, M., & Pretorius, P. J. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1448.022 · Cited by 190 · see citing works
Ser-249 p53 Mutations in Plasma DNA of Patients With Hepatocellular Carcinoma From The Gambia
Kirk, G. D., Camus-Randon, A.-M., Mendy, M. E., Goedert, J. J., Merle, P., TREPO, C. G., Bréchot, C., Hainaut, P. L., & Montesano, R. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.2.148 · Cited by 190 · see citing works
Vlassov, V. V., Laktionov, P. P., & RYKOVA, E. Y. (2007) · BioEssays · doi:10.1002/bies.20604 · Cited by 182 · see citing works
Detection of Solid Tumor Molecular Residual Disease (MRD) Using Circulating Tumor DNA (ctDNA)
Chin, R.-I., Chen, K., Usmani, A., Chua, C., Harris, P. K., Binkley, M. S., Azad, T. D., Dudley, J. C., & Chaudhuri, A. A. (2019) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-019-00390-5 · Cited by 191 · see citing works
Genomic analysis of circulating cell-free DNA infers breast cancer dormancyPreprint
Shaw, J., Page, K., Blighe, K., Hava, N., Guttery, D. S., Ward, B., Brown, J., Ruangpratheep, C., Stebbing, J., Payne, R., et al. (2011) · Genome Research · doi:10.1101/gr.123497.111 · Cited by 180 · see citing works
Detection of mutant K-ras DNA in plasma or serum of patients with colorectal cancer
KOPRESKI, M. S., Benko, F. A., Kwee, C., Leitzel, K. E., Eskander, E., Lipton, A., & Gocke, C. D. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.551 · Cited by 172 · see citing works
Plasma cell‐free DNA in ovarian cancer
Kamat, A. A., Baldwin, M., Urbauer, D. L., Dang, D. H., Han, L. Y., Godwin, A. K., Karlan, B. Y., Simpson, J. L., Gershenson, D. M., Coleman, R. L., et al. (2010) · Cancer · doi:10.1002/cncr.24997 · Cited by 169 · see citing works
Mattox, A. K., Douville, C. B., Wang, Y., Popoli, M., Ptak, J., Silliman, N., Dobbyn, L., Schaefer, J., Lu, S., Pearlman, A. H., et al. (2023) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-1252 · Cited by 166 · see citing works
Potential clinical utility of liquid biopsies in ovarian cancer
Zhu, J. W., Charkhchi, P., & Akbari, M. R. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01588-8 · Cited by 161 · see citing works
Yamada, T., Nakamori, S., Ohzato, H., Oshima, S., Aoki, T., HIGAKI, N., Sugimoto, K., Akagi, K., Fujiwara, Y., Nishisho, I., et al. (1998) · PubMed · Cited by 159 · see citing works
Kumar, S. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2005.062893 · Cited by 154 · see citing works
Use of Liquid Biopsies in Clinical Oncology: Pilot Experience in 168 Patients
Schwaederle, M. C., Husain, H., Fanta, P. T., Piccioni, D. E., Kesari, S., Schwab, R. B., Patel, S. P., Harismendy, O., Ikeda, M., Parker, B. A., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0318 · Cited by 152 · see citing works
Schmiegel, W., Scott, R. J., Dooley, S., Lewis, W., Meldrum, C. J., Pockney, P. G., Draganic, B. D., Smith, S., Hewitt, C., Phillimore, H., et al. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12023 · Cited by 152 · see citing works
Cell‐free DNA as a biomarker of aging
Teo, Y. V., Capri, M., Morsiani, C., Pizza, G., Faria, A. M. C., Franceschi, C., & Neretti, N. (2018) · Aging Cell · doi:10.1111/acel.12890 · Cited by 152 · see citing works
Gouas, D. A., Shi, H., & Hainaut, P. L. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.02.057 · Cited by 151 · see citing works
Circulating biomarkers to monitor cancer progression and treatment
Rapisuwon, S., Vietsch, E. E., & Wellstein, A. (2016) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2016.05.004 · Cited by 138 · see citing works
Application of liquid biopsy in precision medicine: opportunities and challenges
Wang, J., Chang, S., Li, G., & Sun, Y. (2017) · Frontiers of Medicine · doi:10.1007/s11684-017-0526-7 · Cited by 138 · see citing works
Utility of Genomic Analysis In Circulating Tumor DNA from Patients with Carcinoma of Unknown Primary
Kato, S., Krishnamurthy, N., Banks, K. C., De, P. K., Williams, K. A., Williams, C. B., Leyland-Jones, B. R., Lippman, S. M., Lanman, R. B., & Kurzrock, R. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0628 · Cited by 134 · see citing works
Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer
Paci, M., Maramotti, S., Bellesia, E., Formisano, D., Albertazzi, L., Ricchetti, T., Ferrari, G., Annessi, V., Lasagni, D., Carbonelli, C. M., et al. (2008) · Lung Cancer · doi:10.1016/j.lungcan.2008.07.012 · Cited by 133 · see citing works
Biomarkers for early detection of breast cancer: What, when, and where?
LEVENSON, V (2007) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2007.01.017 · Cited by 131 · see citing works
Aberrant DNA methylation of the p16INK4a gene in plasma DNA of breast cancer patients
Silva, J. M., Domínguez, G., Villanueva, M. J., Gonzalez, R., Garcia, J. M., Corbacho, C., Provencio, M., España, P., & Bonilla, F. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690495 · Cited by 129 · see citing works
Liquid biopsy for cancer screening, patient stratification and monitoring
Brock, G., Castellanos-Rizaldos, E., Hu, L., Coticchia, C. M., & Skog, J. (2018) · Translational Cancer Research · doi:10.21037/4546 · Cited by 131 · see citing works
An Overview on the Isolation and Analysis of Circulating Tumor DNA in Plasma and Serum
Jen, J., Wu, L. J., & Sidransky, D. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06581.x · Cited by 128 · see citing works
Measurement of an apoptotic product in the sera of breast cancer patients
Ueno, T., Toi, M., Bivén, K., Bando, H., Ogawa, T., & Linder, S. T. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00865-1 · Cited by 127 · see citing works
Circulating cell-free DNA: A novel biomarker for response to therapy in ovarian carcinoma
Kamat, A. A., Bischoff, F. Z., Dang, D., Baldwin, M. R., Han, L. Y., Lin, Y. G., Merritt, W. M., Landen, C. N., Lu, C., Gershenson, D. M., et al. (2006) · Cancer Biology & Therapy · doi:10.4161/cbt.5.10.3240 · Cited by 127 · see citing works
Diagnostic and prognostic value of circulating tumor-related DNA in cancer patients
Marzese, D. M., Hirose, H., & Hoon, D. S. �. (2013) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2013.845088 · Cited by 123 · see citing works
Circulating DNA fragmentomics and cancer screening
Thierry, A. R. (2023) · Cell Genomics · doi:10.1016/j.xgen.2022.100242 · Cited by 125 · see citing works
Circulating Nucleic Acids in Plasma and Serum
Gahan, P. B., & Swaminathan, R. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1448.050 · Cited by 120 · see citing works
Mehra, N., Penning, M. T., Maas, J., van Daal, N., Giles, R. H., & Voest, E. E. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1087 · Cited by 115 · see citing works
Benešová, L., Belšánová, B., Suchánek, Š., Kopeckova, M., Mináriková, P., Lipská, L., Levý, M., Visokai, V., Zavoral, M., & Minárik, M. (2012) · Analytical Biochemistry · doi:10.1016/j.ab.2012.06.018 · Cited by 109 · see citing works
Fujiwara, Y., Chi, D. D., Wang, H., Keleman, P., Morton, D. L., Turner, R. R., & Hoon, D. S. �. (1999) · PubMed · Cited by 108 · see citing works
Recovering circulating extracellular or cell-free RNA from bodily fluids
Tzimagiorgis, G., Michailidou, E. Z., Κritis, A., Markopoulos, A. K., & Kouidou, S. (2011) · Cancer Epidemiology · doi:10.1016/j.canep.2011.02.016 · Cited by 107 · see citing works
The epigenetics of oral cancer
Shaw, R. (2005) · International Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.ijom.2005.06.014 · Cited by 107 · see citing works
Cell-Free DNA Fragmentomics: The Novel Promising Biomarker
Qi, T., Pan, M., Shi, H., Wang, L., Bai, Y., & Ge, Q. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021503 · Cited by 102 · see citing works
Microsatellite alterations plasma DNA of primary breast cancer patients.
Shaw, J., Smith, B., Walsh, T., Johnson, S., Primrose, L., Slade, M. J., Walker, R. A., & Coombes, R. C. (2000) · PubMed · Cited by 99 · see citing works
Release of DNA from Dead and Dying Lymphocyte and Monocyte Cell Lines In Vitro
Choi, J. ‐., Reich, C. F., & Pisetsky, D. S. (2004) · Scandinavian Journal of Immunology · doi:10.1111/j.0300-9475.2004.01470.x · Cited by 97 · see citing works
Conway, A., Mitchell, C. L., Kilgour, E., Brady, G., Dive, C., & Cook, N. (2018) · British Journal of Cancer · doi:10.1038/s41416-018-0332-2 · Cited by 96 · see citing works
Cell free DNA as a diagnostic and prognostic marker for cardiovascular diseases
Polina, I. A., Ilatovskaya, D. V., & DeLeon‐Pennell, K. Y. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.01.013 · Cited by 95 · see citing works
At the dawn: cell-free DNA fragmentomics and gene regulation
Liu, Y. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01635-z · Cited by 98 · see citing works
Role of macrophages in the generation of circulating blood nucleosomes from dead and dying cells
Jiang, N., Reich, C. F., & Pisetsky, D. S. (2003) · Blood · doi:10.1182/blood-2002-10-3312 · Cited by 94 · see citing works
Cell-free DNA approaches for cancer early detection and interception
Medina, J. E., Dracopoli, N. C., Bach, P. B., Lau, A., Scharpf, R. B., Meijer, G. A., Andersen, C. L., & Velculescu, V. E. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-006013 · Cited by 93 · see citing works
Quantification of Circulating DNA in the Plasma and Serum of Cancer Patients
Taback, B., O'Day, S. J., & Hoon, D. S. �. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1318.004 · Cited by 91 · see citing works
Genomic and fragmentomic landscapes of cell-free DNA for early cancer detection
Bruhm, D. C., Vulpescu, N. A., Foda, Z. H., Phallen, J. A., Scharpf, R. B., & Velculescu, V. E. (2025) · Nature reviews. Cancer · doi:10.1038/s41568-025-00795-x · Cited by 99 · see citing works
Increased Plasma Circulating Cell-Free DNA Could Be a Potential Marker for Oral Cancer
Lin, L.-H., Chang, K., Kao, S., Cheng, H.-W., & Liu, C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113303 · Cited by 87 · see citing works
Sorenson, G. D. (2000) · PubMed · Cited by 85 · see citing works
Sandulache, V. C., Williams, M. D., Lai, S. Y., Lu, C., William, W. N., Busaidy, N. L., Cote, G. J., Singh, R. R., Luthra, R., & Cabanillas, M. E. (2016) · Thyroid · doi:10.1089/thy.2016.0076 · Cited by 84 · see citing works
Increased integrity of circulating cell-free DNA in plasma of patients with acute leukemia
Gao, Y., He, Y., Yang, Z., Shao, H.-Y., Zuo, Y., Bai, Y., Chen, H., Chen, X., Qin, F., Tan, S., et al. (2010) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2010.311 · Cited by 83 · see citing works
Rozenblum, A. B., Ilouze, M., Dudnik, E., Dvir, A., Soussan‐Gutman, L., Geva, S., & Peled, N. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.10.021 · Cited by 80 · see citing works
Validation of a blood plasma separation system by biomarker detection
Kersaudy-Kerhoas, M., Kavanagh, D. M., Dhariwal, R. S., Campbell, C. J., & Desmulliez, M. P. Y. (2010) · Lab on a Chip · doi:10.1039/b926834k · Cited by 80 · see citing works
Sonnenberg, A., Marciniak, J. Y., McCanna, J. P., Krishnan, R., Rassenti, L. Z., Kipps, T. J., & Heller, M. J. (2013) · Electrophoresis · doi:10.1002/elps.201200444 · Cited by 79 · see citing works
Liquid biopsy and non-small cell lung cancer: are we looking at the tip of the iceberg?
Bonanno, L., Maso, A. D., Pavan, A., Zulato, E., Calvetti, L., Pasello, G., Guarneri, V., Conte, P., & Indraccolo, S. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-01777-8 · Cited by 79 · see citing works
Krishnan, R., Sullivan, B. D., Mifflin, R. L., Esener, S. C., & Heller, M. J. (2008) · Electrophoresis · doi:10.1002/elps.200800037 · Cited by 79 · see citing works
Czeiger, D., Shaked, G., Eini, H., Vered, I., Belochitski, O., Avriel, A., Ariad, S., & Douvdevani, A. (2011) · American Journal of Clinical Pathology · doi:10.1309/ajcp4rk2ihvkttzv · Cited by 77 · see citing works
Circulating cell-free DNA and circulating tumor cells, the “liquid biopsies” in ovarian cancer
Cheng, X., Zhang, L., Chen, Y., & Qing, C. (2017) · Journal of Ovarian Research · doi:10.1186/s13048-017-0369-5 · Cited by 76 · see citing works
Nucleic acid-based biomarkers in body fluids of patients with urologic malignancies
Ralla, B., Stephan, C., Meller, S., Dietrich, D., Kristiansen, G., & Jung, K. (2014) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2014.914888 · Cited by 75 · see citing works
- Authors
- Stroun, M., Anker, P., Lyautey, J., Lederrey, C., & Maurice, P. A.
- Affiliations
- University of Geneva (CH)
- University Hospital of Geneva (CH)
- Venue
- European Journal of Cancer and Clinical Oncology
- Publisher
- Elsevier BV
- Published
- 1987-06
- Volume
- 23
- Issue
- 6
- Pages
- 707-712
- ISSN
- 0277-5379 (ISSN-L)
- OpenAlex
- W2058440954
- Cited by
- 373
- References
- 17
- Citations by year
- 2026: 8 · 2025: 9 · 2024: 7 · 2023: 18 · 2022: 16 · 2021: 21 · 2020: 21 · 2019: 29 · 2018: 27 · 2017: 13 · 2016: 13 · 2015: 10 · 2014: 15 · 2013: 11 · 2012: 18
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Cancer and Clinical Oncology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Advanced biosensing and bioanalysis techniques
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Keywords
- circulating tumor DNA, plasma DNA, cancer patients, DNA extraction, DNA purification, double-stranded DNA, DNA fragment size distribution, DNA hybridization, malignancy marker
- MeSH terms
- DNA, Neoplasm, Electrophoresis, Agar Gel, Humans, Neoplasms, Nucleic Acid Hybridization
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review